SoMDZ — Society of Mesotherapy of Algeria — Medical Advisory
Clinical Research &
Product Evaluation
by SoMDZ
SoMDZ — the
Society of Mesotherapy of Algeria
— is a recognised scientific partner for pharmaceutical companies, medical device manufacturers, and aesthetic product innovators seeking independent, evidence-based clinical evaluation of their products in a real-world practice setting.
Enquire About a Partnership →
Why SoMDZ
“We are not just a training organisation. We are a clinical authority. When a company needs credible, independent evaluation of a new product in mesotherapy, skin boosters, exosomes or polynucleotides — backed by a professional society, carried out by specialist practitioners, and published to a standard the industry can trust — SoMDZ is uniquely positioned to deliver that.”
What SoMDZ Offers to Industry Partners
SoMDZ works with pharmaceutical companies, medical device manufacturers, and aesthetic product innovators to provide
independent clinical evaluation, product outcome studies, and real-world evidence generation
in the field of injectable aesthetic medicine.
Our Medical Advisory Board can design, conduct, and report on clinical studies that give your product the independent, authoritative evidence base it needs to reach the aesthetic medicine market with confidence.
If your company is developing, launching, or seeking to strengthen the evidence base for a product in any of the treatment categories below, we invite you to contact us to discuss a research partnership.
Treatment Areas — Our Clinical Expertise
SoMDZ’s clinical expertise spans the full range of injectable aesthetic and pain management techniques. We can design and conduct product evaluations across all of the following categories:
| Treatment Category |
What we can evaluate for your product |
| Mesotherapy |
Cocktail efficacy, ingredient bioavailability, skin quality and hair restoration outcomes, patient satisfaction, technique optimisation, protocol development, comparative studies. |
| Skin Boosters |
Hydration, elasticity and luminosity outcomes, patient-reported outcomes, longevity of effect, comparison with existing CE-marked products, injection-protocol and usability assessment. |
| Exosomes |
Regenerative outcomes, skin firmness and texture, post-procedure recovery, comparative studies with PRP and polynucleotides, safety assessment, combined-protocol outcomes. |
| Polynucleotides (PDRN / PN) |
Tissue repair, collagen and elastin stimulation, periorbital and skin-laxity applications, hair restoration efficacy, pain-management applications, combined-protocol studies. |
| Pain Mesotherapy |
Musculoskeletal pain outcomes (osteoarthritis, low back pain, tendonitis, cervical pain), comparison with corticosteroid injection, function-score improvement (WOMAC, VAS, Oxford Knee Scale), quality-of-life assessment. |
| Combined Protocols |
Multi-product protocol development and outcome assessment — the additive or synergistic effect of your product alongside botulinum toxin, dermal fillers, laser or radiofrequency devices. |
| New Products & Formulations |
First clinical-use assessment, practitioner usability, patient tolerability and satisfaction, outcome reporting for CE-marking dossier support, real-world evidence for PMCF requirements. |
What a SoMDZ Research Partnership Includes
01
Independent Clinical Evaluation
Product assessment by SoMDZ Medical Advisory Board members in a real-world clinical practice setting, independent of the manufacturer, reported objectively.
02
Outcome Studies & Data Collection
Structured data collection using validated outcome measures (VAS, GAIS, WSRS, FACE-Q, WOMAC, Oxford Knee Scale). Patient- and practitioner-reported outcomes.
03
Protocol Development
Collaborative development of injection protocols, treatment sequences and clinical guidelines for your product, grounded in the board’s clinical expertise.
04
Written Reports & Publications
Formal outcome reports suitable for internal use, regulatory dossiers, PMCF, or peer-reviewed publication — authored by SoMDZ Medical Advisory Board members.
05
Practitioner Network Access
Access to SoMDZ’s network of accredited mesotherapy practitioners for multi-centre studies, larger samples and real-world evidence generation.
06
SoMDZ Authority & Endorsement
Research under the SoMDZ name carries the credibility of Algeria’s leading professional mesotherapy society — signalling evaluation to the highest professional standard.
Why Choose SoMDZ as Your Research Partner
Professional Society Authority
SoMDZ is Algeria’s recognised professional society for mesotherapy — not a commercial training company. Research under our name carries the weight of a professional institution.
International Perspective
Our advisory board brings an international clinical perspective to your product evaluation within a single partnership.
Specialism in Injectable Aesthetics
We are not generalists. Our entire clinical focus is injectable aesthetic and pain medicine — mesotherapy, skin boosters, exosomes, polynucleotides.
Active Practitioner Network
SoMDZ members are active practitioners currently injecting patients. Studies run in real clinical settings with genuine patient populations — not artificial trial environments.
Regulatory Awareness
Our board understands the regulatory framework for medical devices and injectables, and can help ensure your evaluation meets post-market clinical follow-up (PMCF) requirements.
Training Integration
Products evaluated and validated by SoMDZ can be integrated into our training curriculum — giving your product direct access to practitioners at the point of clinical education.
How a Partnership Works
1
Initial Enquiry
Contact SoMDZ by email or phone with a brief description of your product, the indication to evaluate, and the evidence you seek. We respond within 2 working days to arrange a preliminary discussion.
2
Scoping Discussion
A call or meeting with SoMDZ Medical Advisory Board members to understand your product, its intended use, and the questions you need answered — and to agree methodology, outcome measures and timeline.
3
Protocol Design
SoMDZ designs the evaluation protocol — subjects, treatment schedule, outcome measures, data collection, follow-up intervals and reporting format — agreed with the company before any clinical work begins.
4
Clinical Evaluation
The evaluation is conducted by SoMDZ Medical Advisory Board members in clinical practice, and/or across SoMDZ’s wider practitioner network depending on scale. All treatments are carried out to SoMDZ’s clinical standards.
5
Outcome Reporting
Data is analysed and a formal written outcome report is produced, authored by SoMDZ Medical Advisory Board members — suitable for internal use, regulatory submissions, PMCF, or peer-reviewed publication.
6
Ongoing Partnership
Many SoMDZ partnerships develop into ongoing relationships — product integration into SoMDZ training, endorsement of CE-marked products, and sponsorship giving your brand direct access to the mesotherapy practitioner community.
The Medical Advisory Board
All SoMDZ clinical evaluations are designed and conducted by members of the SoMDZ Medical Advisory Board — a panel of specialist doctors with active clinical practices.
Dr Philippe Hamida-Pisal
International
Key Opinion Leader in aesthetic and regenerative medicine. PhD Dermatology. Practising internationally in aesthetic mesotherapy, skin boosters, exosomes, polynucleotides and combined protocols.
Dr Tania Robakowska
International
Aesthetic medicine specialist with multilingual clinical practice. Expertise in mesotherapy protocols and skin rejuvenation across diverse patient populations.
Dr Corinne Dubois-Gonet
France
Aesthetic medicine specialist trained in the French mesotherapy tradition where the technique was founded — bringing that clinical heritage to the board’s research work.
Dr Jihyun Byun
South Korea
Aesthetic medicine specialist bringing the technical precision and clinical innovation of Korean injectable and regenerative medicine directly to SoMDZ research.
Conflicts of Interest & Independence
All evaluations are conducted independently of the sponsoring company.
Outcome data is reported objectively regardless of results. SoMDZ does not endorse products prior to evaluation, and findings are never manipulated to serve commercial interests. Companies engaging SoMDZ as a research partner agree to these terms before any work begins.
“The aesthetic medicine market is full of products claiming to be the next breakthrough. What separates those that endure is evidence — independent, clinical, credible evidence from practitioners who use these techniques every day. That is what SoMDZ provides. We are not here to validate marketing claims. We are here to find out what actually works — and to report it honestly.”
— SoMDZ Medical Advisory Board
Research Partnership Enquiries
To discuss a clinical evaluation, outcome study, or product research partnership, contact the SoMDZ Medical Advisory Board directly. We respond to all research enquiries within 2 working days.
Address
18, coopérative el zohor, 31000 (Oran), Algérie
Please include a brief description of your product and the type of evaluation you are seeking. All enquiries are treated in strict confidence.
